Dr. Ananda M. Chakrabarty
Dr. Ananda M. Chakrabarty, Amrita’s Senior Science Mentor, is the global domain expert relating to how bacterial proteins effectively combat cancers, parasites, and viruses in the human body.
Dr. Chakrabarty is a Distinguished University Professor of microbiology and immunology at the University of Illinois College of Medicine, and advises senior officials in the U.S. and abroad on policies relating to biotechnology and related technology transfer. As a consultant to the United Nations, Dr. Chakrabarty was a part of the advisory committee that resulted in creation of the International Center for Genetic Engineering and Biotechnology (ICGEB) in Trieste, Italy, and has recently rejoined the ICGEB Advisory Board.
In 1980, Dr. Chakrabarty’s genetically modified Pseudomonas bacteria became the first genetically-engineered organism to gain a patent, as a result of the Supreme Court decision in Diamond vs. Chakrabarty. Dr. Chakrabarty has continued to undertake pioneering biotechnology research into the therapeutic potential for protein products of bacteria, both at the University of Illinois at Chicago (UIC) and on behalf of CDG Therapeutics, a U.S. biotechnology start-up company engaged in clinical cancer research. Dr. Chakrabarty has led path-breaking research into the therapeutic qualities of protein products of bacteria. This work includes recent studies with water-soluble products of pathogenic bacteria demonstrating significant promise for cancer therapies which will also be effective against HIV/AIDS, malaria and perhaps even tuberculosis.
Dr. Chakrabarty has numerous publications and has received many notable awards for his contributions to biotechnology, including most recently the Padma Shri (2007), one of the Indian Government’s highest civilian honors. A full listing of his scientific advisory memberships, related professional activities, awards and recent publications is available here.